Becky Slagle‐Webb

1.4k total citations
35 papers, 1.2k citations indexed

About

Becky Slagle‐Webb is a scholar working on Molecular Biology, Hematology and Neurology. According to data from OpenAlex, Becky Slagle‐Webb has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Hematology and 8 papers in Neurology. Recurrent topics in Becky Slagle‐Webb's work include Iron Metabolism and Disorders (10 papers), Glioma Diagnosis and Treatment (6 papers) and Neuroblastoma Research and Treatments (6 papers). Becky Slagle‐Webb is often cited by papers focused on Iron Metabolism and Disorders (10 papers), Glioma Diagnosis and Treatment (6 papers) and Neuroblastoma Research and Treatments (6 papers). Becky Slagle‐Webb collaborates with scholars based in United States, Italy and Australia. Becky Slagle‐Webb's co-authors include James R. Connor, Achuthamangalam B. Madhankumar, Jonas M. Sheehan, Akiva Mintz, Nodar Surguladze, Denise M. Gibo, Waldemar Debinski, Anna Cozzi, Xuesheng Zhang and William E. Seaman and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Becky Slagle‐Webb

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Becky Slagle‐Webb United States 14 524 247 209 199 197 35 1.2k
Achuthamangalam B. Madhankumar United States 13 345 0.7× 103 0.4× 114 0.5× 206 1.0× 208 1.1× 19 791
Sabina Świerczek United States 20 453 0.9× 273 1.1× 363 1.7× 165 0.8× 33 0.2× 57 1.1k
Jan Olaf Stracke Switzerland 18 1.0k 1.9× 148 0.6× 57 0.3× 102 0.5× 150 0.8× 26 1.8k
David Colecchia Italy 16 478 0.9× 97 0.4× 89 0.4× 65 0.3× 65 0.3× 19 830
Caroline Desponts United States 16 1.5k 2.9× 138 0.6× 118 0.6× 21 0.1× 216 1.1× 22 2.0k
Ewa Baumann Canada 18 565 1.1× 32 0.1× 57 0.3× 152 0.8× 147 0.7× 31 1.3k
S K Powers United States 12 194 0.4× 117 0.5× 187 0.9× 25 0.1× 101 0.5× 19 799
Hadassah Sade Germany 15 607 1.2× 36 0.1× 71 0.3× 125 0.6× 75 0.4× 32 1.4k
Nicolae Ghinea France 20 806 1.5× 26 0.1× 64 0.3× 254 1.3× 143 0.7× 43 1.8k
Carsten Hagemann Germany 26 1.1k 2.1× 56 0.2× 320 1.5× 51 0.3× 176 0.9× 74 2.0k

Countries citing papers authored by Becky Slagle‐Webb

Since Specialization
Citations

This map shows the geographic impact of Becky Slagle‐Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Becky Slagle‐Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Becky Slagle‐Webb more than expected).

Fields of papers citing papers by Becky Slagle‐Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Becky Slagle‐Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Becky Slagle‐Webb. The network helps show where Becky Slagle‐Webb may publish in the future.

Co-authorship network of co-authors of Becky Slagle‐Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Becky Slagle‐Webb. A scholar is included among the top collaborators of Becky Slagle‐Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Becky Slagle‐Webb. Becky Slagle‐Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Slagle‐Webb, Becky, Chachrit Khunsriraksakul, Jingqin Luo, et al.. (2024). Analysis of anemia and iron supplementation among glioblastoma patients reveals sex-biased association between anemia and survival. Scientific Reports. 14(1). 2389–2389. 1 indexed citations
2.
Khristov, Vladimir, Laura J. Liermann, Dongxiang Wang, et al.. (2024). Analysis of transition metals in glioblastoma tumor and plasma samples.. Journal of Clinical Oncology. 42(16_suppl). e14029–e14029.
3.
Walter, Vonn, Kondaiah Palsa, Becky Slagle‐Webb, et al.. (2023). Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma. Journal of Neuro-Oncology. 164(3). 569–586. 1 indexed citations
4.
Slagle‐Webb, Becky, et al.. (2023). Photodynamic Therapy for Glioblastoma: Illuminating the Path toward Clinical Applicability. Cancers. 15(13). 3427–3427. 31 indexed citations
5.
Ataie, Zaman, Kondaiah Palsa, Chachrit Khunsriraksakul, et al.. (2023). Iron inhibits glioblastoma cell migration and polarization. The FASEB Journal. 37(12). e23307–e23307. 7 indexed citations
6.
Slagle‐Webb, Becky, et al.. (2023). Uptake of H-ferritin by Glioblastoma stem cells and its impact on their invasion capacity. Journal of Cancer Research and Clinical Oncology. 149(12). 9691–9703. 3 indexed citations
7.
Lee, Sang Yup, Becky Slagle‐Webb, Cara‐Lynne Schengrund, Junjia Zhu, & James R. Connor. (2021). Association Between Iron and Cholesterol in Neuroblastomas. Anticancer Research. 41(6). 2795–2804. 4 indexed citations
8.
Lee, Sang Yong, Becky Slagle‐Webb, Arun Sharma, & James R. Connor. (2020). Characterization of a Novel Barbituric Acid and Two Thiobarbituric Acid Compounds for Lung Cancer Treatment. Anticancer Research. 40(11). 6039–6049. 15 indexed citations
10.
Madhankumar, Achuthamangalam B., Oliver Mrowczynski, Becky Slagle‐Webb, et al.. (2018). Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors. PLoS ONE. 13(1). e0181529–e0181529. 8 indexed citations
11.
Mrowczynski, Oliver, et al.. (2017). HFE genotype affects exosome phenotype in cancer. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(8). 1921–1928. 12 indexed citations
12.
Liu, Xiaoli, Achuthamangalam B. Madhankumar, Kari A. Duck, et al.. (2015). MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA. Neuro-Oncology. 18(5). 691–699. 48 indexed citations
13.
Lee, Sang Yong, Becky Slagle‐Webb, Elias Rizk, et al.. (2014). Characterization of a Novel Anti-Cancer Compound for Astrocytomas. PLoS ONE. 9(9). e108166–e108166. 12 indexed citations
14.
Lee, Sang Yong, Siying Liu, Ryan M. Mitchell, et al.. (2010). HFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A. International Journal of Cancer. 129(9). 2104–2114. 22 indexed citations
15.
Madhankumar, Achuthamangalam B., Becky Slagle‐Webb, Xinsheng Wang, et al.. (2009). Efficacy of interleukin-13 receptor–targeted liposomal doxorubicin in the intracranial brain tumor model. Molecular Cancer Therapeutics. 8(3). 648–654. 104 indexed citations
16.
Fisher, Jasmin, Kavi Devraj, Justin Ingram, et al.. (2007). Ferritin: a novel mechanism for delivery of iron to the brain and other organs. American Journal of Physiology-Cell Physiology. 293(2). C641–C649. 172 indexed citations
17.
Surguladze, Nodar, et al.. (2006). Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia. 54(8). 795–804. 138 indexed citations
18.
Madhankumar, Achuthamangalam B., Becky Slagle‐Webb, Akiva Mintz, Jonas M. Sheehan, & James R. Connor. (2006). Interleukin-13 receptor–targeted nanovesicles are a potential therapy for glioblastoma multiforme. Molecular Cancer Therapeutics. 5(12). 3162–3169. 104 indexed citations
19.
Lee, Sang Yup, Becky Slagle‐Webb, Jonas M. Sheehan, & James R. Connor. (2005). Role of HFE mutation in the brain tumors. Cancer Research. 65. 851–851. 1 indexed citations
20.
Mintz, Akiva, et al.. (2002). IL-13Rα2 is a Glioma-Restricted Receptor for Interleukin-13. Neoplasia. 4(5). 388–399. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026